ConductScience.org, home

Paper7409232

A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate.

Fotherby K and 6 others. Fertil Steril, 1980. Cited by 48 papers, by iCite.

Cite this record

ConductScience Library. A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate. Papers, record 7409232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7409232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A preliminary pharmacokinetic and pharmacodynamic evaluation of depot-medroxyprogesterone acetate and norethisterone oenanthate.
PubMed
Journal
Fertil Steril
PubMed
Year
1980
PubMed
Publication types
Comparative Study, Journal Article
PubMed
Citations, by iCite
48
iCite
Relative citation ratio, by iCite
2.14
iCite
Revised in PubMed
2019-07-07
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fotherby KK
2Saxena BNB N
3Shrimanker KK
4Hingorani VV
5Takker DD
6Diczfalusy EE
7Landgren BMB M

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MedroxyprogesteroneMajor topic
NorethindroneMajor topic
Adult
Blood Chemical Analysis
Body Weight
Delayed-Action Preparations
Female
Hematologic Tests
Humans
Kinetics
Menstruation
Ovarian Function Tests

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 48 citations.

PMIDTitleJournalYearIn PapersSource
41489365Injectable contraceptives differentially affect the hypothalamic-pituitary-gonadal axis and amenorrhea incidence†.Biol Reprod2026https://conductscience.org/library/papers/41489365PubMed
39106301U.S. Selected Practice Recommendations for Contraceptive Use, 2024.MMWR Recomm Rep2024https://conductscience.org/library/papers/39106301PubMed
38530848
Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial.
PLoS One2024https://conductscience.org/library/papers/38530848PubMed
38134043Misreporting contraceptive use and the association of peak study progestin levels with weight and BMI among women randomized to the progestin-only injectable contraceptives DMPA-IM and NET-EN.PLoS One2023https://conductscience.org/library/papers/38134043PubMed
35964796Variability and quantification of serum medroxyprogesterone acetate levels.Steroids2022https://conductscience.org/library/papers/35964796PubMed
35941737
Initiating Intramuscular Depot Medroxyprogesterone Acetate Increases Frequencies of Th17-like Human Immunodeficiency Virus Target Cells in the Genital Tract of Women in South Africa: A Randomized Trial.
Clin Infect Dis2022https://conductscience.org/library/papers/35941737PubMed
33316287Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.Pharmacol Ther2021https://conductscience.org/library/papers/33316287PubMed
30867477The contraceptive medroxyprogesterone acetate, unlike norethisterone, directly increases R5 HIV-1 infection in human cervical explant tissue at physiologically relevant concentrations.Sci Rep2019https://conductscience.org/library/papers/30867477PubMed
30585845HIV risk associated with serum medroxyprogesterone acetate levels among women in East and southern Africa.AIDS2019https://conductscience.org/library/papers/30585845PubMed
29698514
Medroxyprogesterone acetate, unlike norethisterone, increases HIV-1 replication in human peripheral blood mononuclear cells and an indicator cell line, via mechanisms involving the glucocorticoid receptor, increased CD4/CD8 ratios and CCR5 levels.
PLoS One2018https://conductscience.org/library/papers/29698514PubMed
29309550Hormonal Contraception and HIV-1 Acquisition: Biological Mechanisms.Endocr Rev2018https://conductscience.org/library/papers/29309550PubMed
29242082Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?Contraception2018https://conductscience.org/library/papers/29242082PubMed
24174884Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.Int J Womens Health2013https://conductscience.org/library/papers/24174884PubMed
16856087Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.Cochrane Database Syst Rev2006https://conductscience.org/library/papers/16856087PubMed
6223801Long acting contraceptives. Present status.Drugs1983https://conductscience.org/library/papers/6223801PubMed
6213318Facts about injectable contraceptives: memorandum from a WHO meeting.Bull World Health Organ1982https://conductscience.org/library/papers/6213318PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/7409232

GET https://conductscience.org/api/papers/v1/7409232/authors